Relapsed or Refractory Hematologic Malignancies

Explore clinical trials studying Relapsed or Refractory Hematologic Malignancies. Study availability and eligibility vary by location and protocol.

6 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Relapsed or Refractory Hematologic Malignancies trial results

Recruiting

NCT03838926

Conditions: Disease Attributes, Hematologic Diseases, Hematologic Neoplasms, +7 more
Locations: Vanda Investigational Site Washington D.C., District of Columbia, United States

Vanda Investigational Site Lafayette, Indiana, United States

Vanda Investigational Site Hackensack, New Jersey, United States

Vanda Investigational Site Seattle, Washington, United States

Recruiting

NCT07173595

Conditions: Disease Attributes, Hematologic Diseases, Hematologic Neoplasms, +7 more
Locations: Peking University People's Hospital Beijing, Beijing Municipality, China

Recruiting

NCT06252298

Conditions: Disease Attributes, Hematologic Diseases, Hematologic Neoplasms, +7 more
Locations: Beijing Chaoyang Hospital ,Capital Medical University Beijing, Beijing Municipality, China

Not Yet Recruiting

NCT07485504

Conditions: Disease Attributes, Hematologic Diseases, Hematologic Neoplasms, +7 more
Locations: Hematology Hospital of Chinese Academy of Medical Sciences (Hematology Research Center of Chinese Academy of Medical Sciences) Tianjin, China

Not Yet Recruiting

NCT07107204

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +23 more
Locations: Not specified

Completed

NCT04926285

Conditions: Disease Attributes, Hematologic Diseases, Hematologic Neoplasms, +7 more
Locations: University of Illinois Cancer Center Chicago, Illinois, United States